Experimental Drug Generates Immune Response Against Pancreatic Cancer in People at High Risk
AI KEY TAKEAWAYS (TL;DR)
- Researchers at Johns Hopkins report that an experimental drug targeting one of the most common genetic drivers of pancreatic cancer was safe in humans, and generated durable immune responses aimed at preventing the cancer in people at high risk
- Pancreatic cancer has one of the lowest survival rates of any form, and the developers believe […] The post Experimental Drug Generates Immune Response Against Pancreatic Cancer in People at High Risk appeared first on Good News Network
Why it matters: Highlights progress and positive advancements shaping a better world.
Researchers at Johns Hopkins report that an experimental drug targeting one of the most common genetic drivers of pancreatic cancer was safe in humans, and generated durable immune responses aimed at preventing the cancer in people at high risk. Pancreatic cancer has one of the lowest survival rates of any form, and the developers believe […] The post Experimental Drug Generates Immune Response Against Pancreatic Cancer in People at High Risk appeared first on Good News Network.
More Uplifting POSITIVE Stories
Chinese Commercial Reactor Achieves Nuclear Fusion with Clean Hydrogen-Boron Fuel
Genetic Analysis All But Confirms the Most Unique of Humpback Populations Is Actually a Subspecies
Stunning Collection of Stolen Greek Artifacts Spanning 5,000 Years Were Just Returned to Greece